review of glp 1 Current Insights, Advantages and Challenges Small Molecule Glucagon-like Peptide Receptor Agonists: A Scoping GLP-1 agonists and changes in
Description
Its essential to maintain regular contact with a healthcare professional while using GLP-1 medication
Powell, C
Jelsing J
Introduction Patients with type 2 diabetes mellitus (T2D) and established atherosclerotic cardiovascular disease (ASCVD) face a substantially elevated risk of major adverse cardiovascular events and premature mortality [1,2,3]
